Feto-placental endothelial dysfunction in Gestational Diabetes Mellitus under dietary or insulin therapy

BMC Endocr Disord. 2023 Feb 23;23(1):48. doi: 10.1186/s12902-023-01305-6.

Abstract

Objective: Gestational diabetes mellitus (GDM) is a serious complication in pregnancy. Despite controlling the plasma glucose levels with dietary intervention (GDM-D) or insulin therapy (GDM-I), children born of diabetic mothers suffer more long-term complications from childhood to early adulthood. Placental circulation and nutrient exchange play a vital role in fetal development. Additionally, placental endothelial function is an indicator of vascular health, and plays an important role in maintaining placental circulation for nutrient exchange. This study was conducted to assess changes in fetal endothelial dysfunction in GDM under different interventions during pregnancy.

Methods: The primary human umbilical vein endothelial cells (HUVECs) were obtained from normal pregnant women (n = 11), GDM-D (n = 14), and GDM-I (n = 12) patients. LC-MS/MS was used to identify differentially expressed proteins in primary HUVECs among the three groups, after which Bioinformatics analysis was performed. Glucose uptake, ATP level, apoptosis, and differentially expressed proteins were assessed to investigate changes in energy metabolism.

Results: A total of 8174 quantifiable proteins were detected, and 142 differentially expressed proteins were identified after comparing patients with GDM-D/GDM-I and healthy controls. Of the 142, 64 proteins were upregulated while 77 were downregulated. Bioinformatics analysis revealed that the differentially expressed proteins were involved in multiple biological processes and signaling pathways related to cellular processes, biological regulation, and metabolic processes. According to the results from KEGG analysis, there were changes in the PI3K/AKT signaling pathway after comparing the three groups. In addition, there was a decrease in glucose uptake in the GDM-I (P < 0.01) group. In GDM-I, there was a significant decrease in the levels of glucose transporter 1 (GLUT1) and glucose transporter 3 (GLUT3). Moreover, glucose uptake was significantly decreased in GDM-I, although in GDM-D, there was only a decrease in the levels of GLUT1. ATP levels decreased in GDM-I (P < 0.05) and apoptosis occurred in both the GDM-D and GDM-I groups. Compared to the normal controls, the levels of phosphate AKT and phosphate AMPK over total AKT and AMPK were reduced in the GDM-I group.

Conclusion: In summary, endothelial dysfunction occurred in pregnancies with GDM even though the plasma glucose levels were controlled, and this dysfunction might be related to the degree of glucose tolerance. The energy dysfunction might be related to the regulation of the AKT/AMPK/mTOR signaling pathway.

Keywords: Endothelial dysfunction; Feto-placental; Gestational Diabetes Mellitus; Glucose transporters.

MeSH terms

  • AMP-Activated Protein Kinases / metabolism
  • Adenosine Triphosphate / metabolism
  • Adult
  • Blood Glucose / metabolism
  • Chromatography, Liquid
  • Diabetes, Gestational* / metabolism
  • Endothelium* / physiopathology
  • Female
  • Glucose Transporter Type 1 / metabolism
  • Human Umbilical Vein Endothelial Cells / metabolism
  • Humans
  • Insulin / metabolism
  • Phosphatidylinositol 3-Kinases / metabolism
  • Placenta* / physiopathology
  • Pregnancy
  • Proto-Oncogene Proteins c-akt / metabolism
  • Tandem Mass Spectrometry

Substances

  • Adenosine Triphosphate
  • AMP-Activated Protein Kinases
  • Blood Glucose
  • Glucose Transporter Type 1
  • Insulin
  • Phosphatidylinositol 3-Kinases
  • Proto-Oncogene Proteins c-akt